Online citations, reference lists, and bibliographies.
← Back to Search

Trends And Patterns Of Differences In Chronic Respiratory Disease Mortality Among US Counties, 1980-2014

L. Dwyer-Lindgren, Amelia Bertozzi-Villa, Rebecca W. Stubbs, Chloe Morozoff, Shreya Shirude, M. Naghavi, A. Mokdad, C. Murray
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Importance Chronic respiratory diseases are an important cause of death and disability in the United States. Objective To estimate age-standardized mortality rates by county from chronic respiratory diseases. Design, Setting, and Participants Validated small area estimation models were applied to deidentified death records from the National Center for Health Statistics and population counts from the US Census Bureau, National Center for Health Statistics, and Human Mortality Database to estimate county-level mortality rates from 1980 to 2014 for chronic respiratory diseases. Exposure County of residence. Main Outcomes and Measures Age-standardized mortality rates by county, year, sex, and cause. Results A total of 4 616 711 deaths due to chronic respiratory diseases were recorded in the United States from January 1, 1980, through December 31, 2014. Nationally, the mortality rate from chronic respiratory diseases increased from 40.8 (95% uncertainty interval [UI], 39.8-41.8) deaths per 100 000 population in 1980 to a peak of 55.4 (95% UI, 54.1-56.5) deaths per 100 000 population in 2002 and then declined to 52.9 (95% UI, 51.6-54.4) deaths per 100 000 population in 2014. This overall 29.7% (95% UI, 25.5%-33.8%) increase in chronic respiratory disease mortality from 1980 to 2014 reflected increases in the mortality rate from chronic obstructive pulmonary disease (by 30.8% [95% UI, 25.2%-39.0%], from 34.5 [95% UI, 33.0-35.5] to 45.1 [95% UI, 43.7-46.9] deaths per 100 000 population), interstitial lung disease and pulmonary sarcoidosis (by 100.5% [95% UI, 5.8%-155.2%], from 2.7 [95% UI, 2.3-4.2] to 5.5 [95% UI, 3.5-6.1] deaths per 100 000 population), and all other chronic respiratory diseases (by 42.3% [95% UI, 32.4%-63.8%], from 0.51 [95% UI, 0.48-0.54] to 0.73 [95% UI, 0.69-0.78] deaths per 100 000 population). There were substantial differences in mortality rates and changes in mortality rates over time among counties, and geographic patterns differed by cause. Counties with the highest mortality rates were found primarily in central Appalachia for chronic obstructive pulmonary disease and pneumoconiosis; widely dispersed throughout the Southwest, northern Great Plains, New England, and South Atlantic for interstitial lung disease; along the southern half of the Mississippi River and in Georgia and South Carolina for asthma; and in southern states from Mississippi to South Carolina for other chronic respiratory diseases. Conclusions and Relevance Despite recent declines in mortality from chronic respiratory diseases, mortality rates in 2014 remained significantly higher than in 1980. Between 1980 and 2014, there were important differences in mortality rates and changes in mortality by county, sex, and particular chronic respiratory disease type. These estimates may be helpful for informing efforts to improve prevention, diagnosis, and treatment.
This paper references
Bayesian modelling of inseparable space-time variation in disease risk.
L. Knorr-Held (2000)
Diagnosed and Undiagnosed Diabetes Prevalence by County in the U.S., 1999–2012
L. Dwyer-Lindgren (2016)
An Analysis of Disparities in Health Status and Access to Health Care in the Appalachian Region. Washington, DC: Appalachian Regional Commission;2004
JA Halverson (2016)
Atlas of respiratory disease mortality, United States: 1982-1993
J. Kim (1998)
50-Year trends in smoking-related mortality in the United States
M. Thun (2013)
Trends in the Use, Sociodemographic Correlates, and Undertreatment of Prescription Medications for Chronic Obstructive Pulmonary Disease among Adults with Chronic Obstructive Pulmonary Disease in the United States from 1999 to 2010
E. Ford (2014)
Changing Patterns of Pneumoconiosis Mortality — United States , 1968 – 2000
C RobertF.FaganDeborahA.AdamsFeliciaJ.ConnorLatekaDa (2004)
Algorithms for enhancing public health utility of national causes-of-death data
M. Naghavi (2010)
An Iterative Procedure for Estimation in Contingency Tables
S. Fienberg (1970)
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society
A. Qaseem (2011)
Estimation of Disease Rates in Small Areas: A new Mixed Model for Spatial Dependence
B. Leroux (2000)
US Spending on Personal Health Care and Public Health, 1996-2013.
J. Dieleman (2016)
Asbestosis mortality in the USA: facts and predictions
V. C. dos Santos Antao (2008)
Cigarette smoking prevalence in US counties: 1996-2012
L. Dwyer-Lindgren (2014)
US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014.
L. Dwyer-Lindgren (2016)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
M. Forouzanfar (2016)
Statistical models in epidemiology, the environment, and clinical trials
M. Halloran (2000)
Intercensal county estimates by age, sex, race: 1980-1989
US Census Bureau (2009)
Pneumoconiosis and advanced occupational lung disease among surface coal miners--16 states, 2010-2011.
Multilevel regression and poststratification for small-area estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system.
Xingyou Zhang (2014)
Fine-Particulate Air Pollution and Life Expectancy in the United States
J. Stockman (2010)
Centers for Disease Control and Prevention. Changing patterns of pneumoconiosis mortality—United States, 1968-2000.MMWRMorb Mortal
M Attfield (2004)
50-Year Trends in Smoking-Related Mortality in the United States
M. Thun (2013)
TMB: Automatic Differentiation and Laplace Approximation
K. Kristensen (2015)
Atlas of United States Mortality
L. W. Pickle (1996)
Epidemiology of chronic obstructive pulmonary disease: a literature review
C. Rycroft (2012)
National trends in silicosis mortality in the United States, 1981-2004.
K. M. Bang (2008)
Prevalence, Awareness, Treatment, and Control of Hypertension in United States Counties, 2001–2009
Casey Olives (2013)
COPD Surveillance—United States, 1999-2011
E. Ford (2013)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Nicholas J. Kassebaum (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
H. Wang (2016)
Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States
J. Holt (2011)
Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.
D. Mannino (2000)
Centers for Disease Control and Prevention. Pneumoconiosis and advanced occupational lung disease among surface coal miners—16 states, 2010-2011.MMWRMorb
AS Laney (2012)

This paper is referenced by
Use of Biomarkers in Chronic Obstructive Pulmonary Disease: Clinical Implications
Ji-Yong Moon (2018)
Progressive massive fibrosis in workers outside the coal industry: A case series from New Mexico
L. Casaus (2019)
Caring for Miners During the Coronavirus Disease‐2019 (COVID‐19) Pandemic
Akshay Sood (2020)
Place of Death for Individuals with Chronic Lung Disease: Trends and Associated Factors from 2003 to 2017 in the United States.
Sarah H Cross (2020)
Exacerbation-Prone Asthma.
L. Denlinger (2019)
Diagnostic Delay in Idiopathic Pulmonary Fibrosis: Where the Rubber Meets the Road.
A. Adegunsoye (2019)
Geographic Distribution of Racial Differences in Prostate Cancer Mortality
Sean A. Fletcher (2020)
Maternal mortality ratios in 2852 Chinese counties, 1996–2015, and achievement of Millennium Development Goal 5 in China: a subnational analysis of the Global Burden of Disease Study 2016
J. Liang (2018)
Assessment of particulate matter toxicity and physicochemistry at the Claim 28 uranium mine site in Blue Gap, AZ
Jessica Begay (2020)
Factors Associated With County-Level Variation in Premature Mortality Due to Noncommunicable Chronic Disease in the United States, 1999-2017
Suhang Song (2020)
Saturated Fat Intake Is Associated with Lung Function in Individuals with Airflow Obstruction: Results from NHANES 2007–2012
Kasey Cornell (2019)
Dietary factors during pregnancy and atopic outcomes in childhood: A systematic review from the European Academy of Allergy and Clinical Immunology
C. Venter (2020)
Rice Consumption and Subclinical Lung Disease in US Adults: Observational Evidence from the Multi-Ethnic Study of Atherosclerosis.
T. Sánchez (2019)
Pulmonary Disease Associated With Nonencapsulated Streptococcus pneumoniae
C. S. Martin (2018)
Underutilization of Pulmonary Function Testing in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation: Who are We Missing?
Brett Bade (2020)
Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease
Sanziana R. I. Schiopu (2019)
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
L. Fang (2018)
Changing causes of death for patients with chronic respiratory disease in England, 2005-2015
A. Gayle (2019)
Electrophilic nitrated fatty acids are potential therapeutic candidates for inflammatory and fibrotic lung diseases.
K. Panati (2020)
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
E. Wittbrodt (2019)
CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.
N. Arger (2019)
Epidemiology of sarcoidosis: current findings and future directions
E. Arkema (2018)
Asthma-related mortality in the United States, 1999 to 2015: A multiple causes of death analysis.
V. Kodadhala (2018)
COPD: Does Inpatient Education Impact Hospital Costs and Length of Stay?
H. Hosseini (2019)
Inflammatory Profiles of Asthma and COPD Primary Human Bronchial Epithelial Cells in Response to LPS and an Inflammatory Inhibitor
H. Branscome (2018)
Disparities in Geographic Access to Hospital Outpatient Pulmonary Rehabilitation Programs in the United States.
I. Moscovice (2019)
Epidemiology of Chronic Obstructive Pulmonary Disease.
Lisa Ruvuna (2020)
Addressing Racial Inequities in Breastfeeding in the Southern United States
A. Merewood (2019)
Factors influencing high respiratory mortality in coal-mining counties: a repeated cross-sectional study
Ruoding Shi (2019)
Metal-Induced Pulmonary Fibrosis
N. Assad (2018)
Estimating the long-run relationship between state cigarette taxes and county life expectancy
A. Baum (2019)
Post-1971 Era Uranium Workers in New Mexico Have Significant Lung Disease Burden.
N. Assad (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar